Information Provided By:
Fly News Breaks for February 21, 2020
Feb 21, 2020 | 06:42 EDT
Mizuho analyst Ann Hynes lowered the firm's price target on Mednax (MD) to $22 from $25 and keeps a Neutral rating on the shares. The analyst attributes the stock's 21% selloff yesterday to the mid-point of its 2020 adjusted EBITDA outlook coming in 3% lower than the mid-point of consensus and the "more concerning" announcement of a contract dispute with UnitedHealth (UNH) in four states, that could result in a $70M-$80M headwind to annual revenue if not resolved.
News For MD;UNH From the Last 2 Days
There are no results for your query MD;UNH